Effective features extraction by analyzing heart sound for identifying cardiovascular diseases related to COVID-19: A diagnostic model.

Incidence and exacerbation of some of the cardiovascular diseases in the presence of the coronavirus will lead to an increase in the mortality rate among patients. Therefore, early diagnosis of such diseases is critical, especially during the COVID-19 pandemic (mild COVID-19 infection). Thus, for diagnosing the heart diseases related to the COVID-19, an automatic, non-invasive, and inexpensive method based on the heart sound processing approach is proposed. In the present study, a set of features related to the nature of heart signals is defined and extracted. The investigated features included morphological and statistical features in the heart sound frequencies. By extracting and selecting a set of effective features related to the mentioned diseases, and avoiding to use different segmentation and filtering techniques, dependence on a limited dataset and specific sampling procedures has been eliminated. Different classifiers with various kernels are applied for diagnosis in data unbalanced and balanced conditions. The results showed 93.15% accuracy and 93.72% F1-score using 60 effective features in data balanced conditions. The identification system using the extracted features from Azad dataset is able to achieve the desired results in a generalized dataset. In this way, in the shortest possible sampling time, the present system provided an effective and generalizable method and a practical model for diagnosing important cardiovascular diseases in the presence of coronavirus in the COVID-19 pandemic.

Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients.

Preventing communicable diseases requires understanding the spread, epidemiology, clinical features, progression, and prognosis of the disease. Early identification of risk factors and clinical outcomes might help in identifying critically ill patients, providing appropriate treatment, and preventing mortality. We conducted a prospective study in patients with flu-like symptoms referred to the imaging department of a tertiary hospital in Iran between March 3, 2020, and April 8, 2020. Patients with COVID-19 were followed up after two months to check their health condition. The categorical data between groups were analyzed by Fisher's exact test and continuous data by Wilcoxon rank-sum test. Three hundred and nineteen patients (mean age 45.48 ± 18.50 years, 177 women) were enrolled. Fever, dyspnea, weakness, shivering, C-reactive protein, fatigue, dry cough, anorexia, anosmia, ageusia, dizziness, sweating, and age were the most important symptoms of COVID-19 infection. Traveling in the past 3 months, asthma, taking corticosteroids, liver disease, rheumatological disease, cough with sputum, eczema, conjunctivitis, tobacco use, and chest pain did not show any relationship with COVID-19. To the best of our knowledge, a number of factors associated with mortality due to COVID-19 have been investigated for the first time in this study. Our results might be helpful in early prediction and risk reduction of mortality in patients infected with COVID-19.